The Company has organized into four divisions: Cannabis Botany Centre, Strategic ACMPR Investments, CBD Oil Supply & Distribution, and Research & Development – to focus Alliance Growers’ potential for success in the medical marijuana market. We have the people to make it happen Meet Our Team
Alliance Growers and B.R.I.M. executed a definitive Exclusive License Agreement on January 23, 2017 whereby B.R.I.M. has granted Alliance Growers an Exclusive License to develop Cannabis Botany Centres in Canada.
The development of the Cannabis Botany Centre will add value to Alliance Growers by providing the following:
Hemp Business Journal estimates the total U.S. CBD market will grow to a $2.1 billion market in consumer sales by 2020 with $450 million of those sales coming from hemp-based sources. Projections to date for 2016 indicate the hemp-derived CBD market is poised to grow to $115 million by the end of the year.
The hemp-derived CBD market grew from a market that was barely noticeable a few years ago to $90 million in 2015 for consumer sales of CBD products. Hemp Business Journal shows another $112 million of marijuana-derived CBD products were sold through dispensaries in 2015, for a total CBD market size of $202 million in 2015 across all hemp and legal marijuana markets.
Through a serious of strategic partnerships and investments under negotiation with Licensed Producers at various stages in the license process, Alliance Growers is focused on securing long term plantlet sale contracts for the Cannabis Botany Centre and off-take agreements at wholesale cost for flower to be acquired by Alliance Growers for CBD oil extraction.
Alliance Growers has negotiated terms on a 5% non-dilutive interest in New Maple Holdings, the parent company of its wholly owned subsidiary, Canwe, a private company in Ontario that has assembled a top tier growing team with management with the expertise to expedite the license producer application process.
Canwe (www.canwe.ca ) is an Ontario-based company that has applied for a producer’s license under the Access to Cannabis for Medical Purposes Regulations (the “ACMPR”). Canwe has access to a 22 acre property 1.5 hours north-west of Toronto, where it plans to build a facility focused on producing clean, premium quality cannabis. Canwe has amassed a stellar team which includes licensed producer MedReleaf Corp.’s former Head Grower and his number two aide, both of whom are expert cannabis growers who intimately know the cannabis cultivation cycle from seed to sale. Investors are encouraged to visit the “Our Edge” section of the Canwe website and watch Master Grower, Jack Yu, at work in his former role as MedReleaf Corp.’s Head Grower. http://canwe.ca/#edge
Alliance currently holds a 50% interest in BC Maramed Production Ltd. (“BCMM”), which owns a leasehold interest and equipment for an 11,000 square foot production facility in Kelowna, British Columbia. BCMM has submitted an application to become a Licensed Producer of medical marijuana under Health Canada’s MMPR program. Upon receipt by BCMM of an approved MMPR Production License from Health Canada, a further 12.5% interest in BCMM will be transferred to Alliance Growers.
Alliance Growers future plans are to continue to seek out further strategic investment opportunities in additional MMPR companies to secure plantlet sales and CBD offtake agreements.
ArcView Market Research released its fourth edition of The State of Legal Marijuana Markets report, and it includes the prediction that the legal cannabis market will see a whopping $21.8 billion in total annual sales by 2020.
Alliance Grower’s goal is to become a world leader in the production and supply of pharmaceutical grade CBD oil. To accomplish this goal Alliance has completed an agreement with B.R.I.M. to build and operate a world class botany centre which will include an extraction and processing of CBD oil.
Alliance Growers has planned an equity investment to finance Canna Companion Products, Inc. Canna is a wholly owned subsidiary of WFS PharmaGreen Inc. that produces and sells safe and effective cannabinoid infused pet products. Canna is a Washington State incorporated company that is the manufacturing, fulfillment and sales centre for the Canna products. This strategic investment in Canna provides two great advantages. One is the investment opportunity and the second agreement gives Alliance Growers the exclusive Canadian CBD oil supply contract from Canna.
Alliance has entered into discussions with an Israeli medical cannabis company to create a joint venture to develop pharmaceutical grade cannabidiol oil (CBD Oil).
Included in the discussions is the joint development of 50 hectares of land for the growth of high quality cannabis plants, as legally permitted in an offshore, low operating cost jurisdiction. It is anticipated that the majority of the plant production would be processed for the extraction of pharmaceutical grade CBD Oil. This would facilitate the importation of the CBD Oil into various states in the USA, into Canada when legalized, and into other countries as permitted.
The potential partner has extensive expertise cultivating world-class marijuana in technical greenhouses. They have a team of scientists, designers, and engineers committed to developing high quality medial cannabis using greenhouses in geographical locations that offer an abundance of natural light. The Company’s R&D is based in Israel and involves both scientific and academic research as well as current ongoing registered medical clinical studies.
The Hemp Business Journal reports that the CBD market is growing at a rate of 30% per annum, and forecasts that sales of CBD Oils from marijuana-based sources are expected to reach $1,650,000,000, or- 79% of the Total CBD Market of $2,100,000,000 by 2020.
Under the guidance of Peter Wojcik and Dr.Fawzia Afreen, the Company will be heavily engaged in research and development through Botanical Research In Motion International Inc. (“B.R.I.M.”).
ACG has moved to develop B.R.I.M whereby B.R.I.M. will allow Alliance Growers to jointly develop and operate multiple cannabis focused Botany Centres in Canada and will include the following:
1 – B.R.I.M.’s proprietary “Chibafreen Invitro Plant Production System”
Utilizing its proprietary state of art clean tissue culture lab room designed to produce over one million Tissue Culture Plantlets per year. The design is scalable and designed for all flora to serve the entire agriculture industry.
2 – B.R.I.M.’s proprietary Cryotissue Cold Storage
Utilizing the one-of-a-kind Cryotissue Cold Storage technology for tissue culture preservation and regeneration as needed on long term basis.
3 – Extraction Lab
Provide custom profiles for extraction for botanicals oils for retail market.
Provide extraction services as retail services to cultivators.
4 – Botanical DNA Services Laboratory
Certifying plant tissue as the genetic level.
Additional DNA mapping services.
5 – B.R.I.M’s proprietary research for cannabis for large commercial scale micro propagation production when permitted.